Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Microsatellite Instability: A Predictive Biomarker for Cancer Immunotherapy.

Applied immunohistochemistry & molecular morphology : AIMM - 1 Feb 2018

Chang Liisa, Chang Minna, Chang Hanna M, Chang Fuju

Abstract excerpt

Immunotherapy has shown promising results in various types of cancers. Checkpoint inhibitor drugs developed for cancer immunotherapy have been approved by the US Food and Drug Administration (FDA) for patients with advanced melanoma, non-small cell lung cancer, renal cell carcinoma, bladder cancers, and refractory Hodgkin lymphoma. In the latest announcement, the FDA has granted accelerated approval to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Biomarkers, Pharmacological

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to DNA Repair

Share to Immunotherapy

Share to Microsatellite Instability

Share to United States

Share to United States Food and Drug Administration

Source

Identifiers

PMID: 28877075
DOI: 10.1097/PAI.0000000000000575

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Microsatellite Instability: A Predictive Biomarker for Cancer Immunotherapy.PMID 28877075Read ↗

Microsatellite Instability: From the Implementation of the Detection to a Prognostic and Predictive Role in CancersSemantic proximity Read ↗

Immunotherapy and patients treated for cancer with microsatellite instability.Semantic proximity Read ↗

Microsatellite instability in cancer: a novel landscape for diagnostic and therapeutic approach.Semantic proximity Read ↗

Microsatellite instability and immune checkpoint inhibitors: toward precision medicine against gastrointestinal and hepatobiliary cancersSemantic proximity Read ↗

Microsatellite instability: a review of what the oncologist should knowSemantic proximity Read ↗

Microsatellite Phenotype as a Guide for Immunotherapy in Colorectal Cancer: Current Status and Future Perspectives.Semantic proximity Read ↗

Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacySemantic proximity Read ↗

Microsatellite instability: A 2024 update.Semantic proximity Read ↗

Immunotherapy of MSI Cancer: Facts and HopesSemantic proximity Read ↗

The distinct clinical trajectory, metastatic sites, and immunobiology of microsatellite-instability-high cancersSemantic proximity Read ↗

High microsatellite instability (MSI-H) colorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicineSemantic proximity Read ↗

Microsatellite Instability as a Biomarker for PD-1 BlockadeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.